http://www.bccancer.bc.ca/chemotherapy-protocols-site/Documents/Sarcoma/SAHIPEC_Protocol.pdf WebJun 30, 2024 · Cisplatin (cis-diamminedichloroplatinum-III, CDDP) is an alkylating agent that causes apoptotic cell death by formation of DNA adducts [ 40 ]. Both normothermic and hyperthermic IP application have …
Experience of applying cytoreductive surgery and hyperthermic ...
WebJul 5, 2024 · In this case report, we describe the use of cisplatin during HIPEC in a patient who previously experienced an HSR to systemic oxaliplatin. The patient tolerated HIPEC … WebCISplatin . 100 mg/m² : INTRAPERITONEAL mixed in 3 L of 1.5% dextrose peritoneal dialysis solution with calcium 2.4 mEq/L and perfused for 90 minutes at intraperitoneal temperature 40-42. o: C using open “coliseum” technique and Belmont hyperthermia pump, flow rate 1000 mL/min . DOSES TO BE BASED ON IDEAL BODY WEIGHT (IBW): BSA (m immature fly
Hyperthermic intraperitoneal chemotherapy with cisplatin …
WebAug 27, 2024 · Disulfiram is a drug used to support the treatment of chronic alcoholism. Recently, it has been found to have an off-label ability to inhibit the growth of ovarian cancer cells. However, the original formulation was designed for use via oral administration, which is not suitable to be given by a direct spray on the affected area. Therefore, in this study, … WebNov 17, 2024 · Paclitaxel 135 mg/m 2 continuous IV infusion over 3 h or 24 h on day 1 plus cisplatin 75-100 mg/m 2 IP on day 2 (may reduce dose to 75 mg/m 2) plus paclitaxel 60 mg/m 2 IP on day 8; repeat every... WebThe 3-year overall survival rates were 95% with cisplatin versus 93% with cisplatin plus doxorubicin, and the event-free survival rates were 83% with cisplatin versus 85% with cisplatin plus ... immature follicles and pregnancy